Novo Nordisk A/S (CPH:NOVO.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
323.05
+14.20 (4.60%)
Aug 8, 2025, 4:59 PM CET

Splunk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of DKK 1.44 trillion. The enterprise value is 1.52 trillion.

Market Cap1.44T
Enterprise Value 1.52T

Important Dates

The last earnings date was Wednesday, August 6, 2025.

Earnings Date Aug 6, 2025
Ex-Dividend Date Mar 28, 2025

Share Statistics

Novo Nordisk has 4.44 billion shares outstanding. The number of shares has decreased by -0.57% in one year.

Current Share Class 3.37B
Shares Outstanding 4.44B
Shares Change (YoY) -0.57%
Shares Change (QoQ) +0.01%
Owned by Insiders (%) 0.02%
Owned by Institutions (%) 31.24%
Float 3.19B

Valuation Ratios

The trailing PE ratio is 12.95 and the forward PE ratio is 11.96. Novo Nordisk's PEG ratio is 1.00.

PE Ratio 12.95
Forward PE 11.96
PS Ratio 4.60
PB Ratio 8.54
P/TBV Ratio 23.84
P/FCF Ratio 22.01
P/OCF Ratio 11.81
PEG Ratio 1.00
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.43, with an EV/FCF ratio of 23.24.

EV / Earnings 13.65
EV / Sales 4.86
EV / EBITDA 9.43
EV / EBIT 10.20
EV / FCF 23.24

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.59.

Current Ratio 0.78
Quick Ratio 0.50
Debt / Equity 0.59
Debt / EBITDA 0.62
Debt / FCF 1.52
Interest Coverage 17.27

Financial Efficiency

Return on equity (ROE) is 79.17% and return on invested capital (ROIC) is 42.53%.

Return on Equity (ROE) 79.17%
Return on Assets (ROA) 21.82%
Return on Invested Capital (ROIC) 42.53%
Return on Capital Employed (ROCE) 54.12%
Revenue Per Employee 3.98M
Profits Per Employee 1.42M
Employee Count77,349
Asset Turnover 0.73
Inventory Turnover 1.20

Taxes

In the past 12 months, Novo Nordisk has paid 29.71 billion in taxes.

Income Tax 29.71B
Effective Tax Rate 21.10%

Stock Price Statistics

The stock price has decreased by -61.00% in the last 52 weeks. The beta is 0.27, so Novo Nordisk's price volatility has been lower than the market average.

Beta (5Y) 0.27
52-Week Price Change -61.00%
50-Day Moving Average 431.77
200-Day Moving Average 561.30
Relative Strength Index (RSI) 34.15
Average Volume (20 Days) 11,008,429

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of DKK 311.94 billion and earned 111.07 billion in profits. Earnings per share was 24.95.

Revenue311.94B
Gross Profit 262.83B
Operating Income 148.64B
Pretax Income 140.78B
Net Income 111.07B
EBITDA 159.26B
EBIT 148.64B
Earnings Per Share (EPS) 24.95
Full Income Statement

Balance Sheet

The company has 18.93 billion in cash and 99.27 billion in debt, giving a net cash position of -80.33 billion or -18.08 per share.

Cash & Cash Equivalents 18.93B
Total Debt 99.27B
Net Cash -80.33B
Net Cash Per Share -18.08
Equity (Book Value) 168.07B
Book Value Per Share 37.82
Working Capital -44.82B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 121.53 billion and capital expenditures -56.30 billion, giving a free cash flow of 65.22 billion.

Operating Cash Flow 121.53B
Capital Expenditures -56.30B
Free Cash Flow 65.22B
FCF Per Share 14.68
Full Cash Flow Statement

Margins

Gross margin is 84.26%, with operating and profit margins of 47.65% and 35.61%.

Gross Margin 84.26%
Operating Margin 47.65%
Pretax Margin 45.13%
Profit Margin 35.61%
EBITDA Margin 51.06%
EBIT Margin 47.65%
FCF Margin 20.91%

Dividends & Yields

This stock pays an annual dividend of 11.40, which amounts to a dividend yield of 3.53%.

Dividend Per Share 11.40
Dividend Yield 3.53%
Dividend Growth (YoY) 21.28%
Years of Dividend Growth 7
Payout Ratio 45.63%
Buyback Yield 0.57%
Shareholder Yield 4.10%
Earnings Yield 7.74%
FCF Yield 4.54%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.

Last Split Date Sep 13, 2023
Split Type Forward
Split Ratio 2

Scores

Novo Nordisk has an Altman Z-Score of 7.82 and a Piotroski F-Score of 4.

Altman Z-Score 7.82
Piotroski F-Score 4